Consistency: Internal review/notes are consistent and correct: EEF2K is a Ca2+/calmodulin-dependent alpha-kinase whose sole substrate is eEF2 (core MF GO:0004686 elongation factor-2 kinase activity). This DIRECTLY CONTRADICTS the PN node, which files EEF2K among "elongation factors" and projects GO:0003746 translation elongation factor activity. EEF2K is the regulatory kinase, not an EF. The review even REMOVES GO:0008135 (translation factor activity, RNA binding) as a substrate-conflation error — the same conflation the PN projection makes.
PN story / NEW pressure: Projected GO:0003746 is more_specific_than_existing_goa per dossier, but it is the wrong molecular function for this gene. EEF2K's function is already captured by GO:0004686 (in GOA, ACCEPTed core) and would be better served at the process level by GO:0045900 negative regulation of translational elongation (OLS-verified; already the review's MODIFY target for GO:0006414). The PN term over-reaches / is wrong.
Mapping strategy:EEF2K argues the assorted elongation factors type conflates true EFs (eEF1A/eEF2) with elongation regulators. Projecting GO:0003746 onto a kinase is a category error; recommend excluding kinases/regulators from that type's MF projection.
Evidence alignment: Dossier gives no reference titles. Review anchors PMID:9144159 (alpha-kinase founding paper), PMID:11015200, PMID:23184662 — all VERIFIED and about kinase activity, none supporting EF activity. Divergence: PN node has no citation backing an EF role.
Verdict: Clear mis-mapping — EEF2K is the eEF2 kinase, not a translation elongation factor; GO:0003746 should not be projected. Recommended edits: [MAP] remove GO:0003746 projection for EEF2K; if a shared process is wanted use GO:0045900 negative regulation of translational elongation. Core MF GO:0004686 already in GOA.